drospirenone

Key facts

INN

drospirenone

Brand

YAELA

Route

ORAL-28

Formulation

TABLET, CHEWABLE

Related patents

patent

US 10420758

Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6887675

Tankyrase H, compositions involved in the cell cycle and methods of use

Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6617102

Tankyrase H, compositions involved in the cell cycle and methods of use

Expires Mon Sep 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 6589725

Tankyrase H, compositions involved in the cell cycle and methods of use

Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is drospirenone?

drospirenone (YAELA), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for drospirenone?

YAELA is a marketed brand name for drospirenone. Check FDA Drugs@FDA for the current US label holder.